Sfoglia per AUTORE
ROSSI E
Collezione AO Cuneo

  

Items : 12

Determinants of Covid19 disease and of survival after Covid19 in MPN patients treated with ruxolitinib. in Blood cancer journal / Blood Cancer J. 2023 May 3;13(1):65. doi: 10.1038/s41408-023-00834-6.

2023
AO Cuneo
AOU Città della Salute di Torino
AOU San Luigi di Orbassano

Andriani A; De Stefano V; Cavo M; Vianelli N; Abruzzese E; Latagliata R; Semenzato GC; Cuneo A; Lemoli RM; Krampera M; Bartoletti D; Cattaneo D; Santoni E; Ceglie S; D'Addio A; Rindone G; Mazzoni C; Romagnoli AD; Crugnola M; Miglino M; Bocchia M; Mendicino F; Tatarelli C; Cilloni D; Cavazzini F; Beggiato E; Caocci G; Binotto G; Polverelli N; et alii...

Predictors of Response to Hydroxyurea and Switch to Ruxolitinib in HU-Resistant Polycythaemia VERA Patients: A Real-World PV-NET Study. in Cancers / Cancers (Basel). 2023 Jul 21;15(14):3706. doi: 10.3390/cancers15143706.

2023
AO Cuneo
AOU Città della Salute di Torino

Lemoli RM; Semenzato G; Krampera M; Cuneo A; Pane F; Garibaldi B; Ripamonti A; Mullai R; Mazzoni C; Ceglie S; Polverelli N; Tomassetti S; Martino B; D'Addio A; Mendicino F; Crugnola M; Caocci G; Pugliese N; Heidel FH; Bonifacio M; Tieghi A; Tiribelli M; Binotto G; Cavazzini F; Elli EM; Benevolo G; Paglia S; Breccia M; Auteri G; et alii...

The ChoCO-W prospective observational global study: Does COVID-19 increase gangrenous cholecystitis? in World journal of emergency surgery : WJES / World J Emerg Surg. 2022 Dec 16;17(1):61. doi: 10.1186/s13017-022-00466-4.

2022
AO Cuneo
AOU Città della Salute di Torino

Biffl WL; Lacavalla D; Andreotti D; Bisetto G; Occhionorelli S; Massani M; Griggio G; Tutino R; Catena F; Delis SG; Rossi S; Biondi A; Agnoletti V; Litvin A; Aref H; Angelis ND; Gambarini F; Kaya T; Pisanu A; Gomes FC; Kurtenkov M; Kirkpatrick A; Pararas N; Martino C; Damaskos D; Balogh ZJ; Gendrikson G; Dogjani A; Agresta F; et alii...

Ropeginterferon alfa-2b versus phlebotomy in low-risk patients with polycythaemia vera (Low-PV study): a multicentre, randomised phase 2 trial. in The Lancet. Haematology / Lancet Haematol. 2021 Mar;8(3):e175-e184. doi: 10.1016/S2352-3026(20)30373-2. Epub 2021 Jan 18.

2021
AO Cuneo
AOU Città della Salute di Torino
AOU Novara

Tognoni G; Finazzi MC; Bellini M; Bucelli C; Lunghi F; Vianelli N; Scaffidi L; Betti S; Guglielmelli P; Loscocco GG; Mora B; Cacciola E; Mannarelli C; Patriarca A; Cascavilla N; Rumi E; Siragusa S; Musolino C; Caramella M; Rapezzi D; Ricco A; Carli G; Palandri F; Pane F; Benevolo G; Bonifacio M; Iurlo A; Ciceri F; Ghirardi A; et alii...

Second cancers in MPN: Survival analysis from an international study. in American journal of hematology / Am J Hematol. 2020 Mar;95(3):295-301. doi: 10.1002/ajh.25700. Epub 2019 Dec 22.

2020
ASL Asti
AO Cuneo
AOU Città della Salute di Torino
ASL Vercelli

Barbui T; Rambaldi A; Alvarez-Larran A; Vannucchi AM; Griesshammer M; Pane F; De Stefano V; Tieghi A; Isfort S; Recasens V; McMullin MF; Cacciola R; Carli G; Benevolo G; Angona A; Fox ML; Beggiato E; Lunghi F; Wille K; Perez-Encinas M; Rapezzi D; Erez D; Gomez M; Palova M; Casetti IC; Stephenson C; Elli EM; Guglielmelli P; Rumi E; et alii...

Arterial thrombosis in Philadelphia-negative myeloproliferative neoplasms predicts second cancer: a case-control study. in Blood / Blood. 2020 Jan 30;135(5):381-386. doi: 10.1182/blood.2019002614.

2020
ASL Asti
AO Cuneo
AOU Città della Salute di Torino
ASL Vercelli
AOU Novara

Di Veroli A; Vannucchi AM; Barbui T; Rambaldi A; Griesshammer M; Alvarez-Larran A; Isfort S; Marchetti M; McMullin MF; Tieghi A; Recasens V; Carli G; Cacciola R; Benevolo G; Fox ML; Beggiato E; Lunghi F; Angona A; Wille K; Perez-Encinas M; Erez D; Gomez M; Rapezzi D; Palova M; Patriarca A; Rumi E; Casetti IC; Stephenson C; Guglielmelli P; et alii...

Distinct HR expression patterns significantly affect the clinical behavior of metastatic HER2+ breast cancer and degree of benefit from novel anti-HER2 agents in the real world setting. in International journal of cancer / Int J Cancer. 2020 Apr 1;146(7):1917-1929. doi: 10.1002/ijc.32583. Epub 2019 Aug 7.

2020
AO Cuneo

Vici P; Di Leo A; Barba M; Villa A; Ciliberto G; Sperduti I; De Maria R; Risi E; Generali D; De Tursi M; Sarobba G; Del Medico P; Meattini I; Desideri I; Livi L; Baldini E; Di Cocco B; Foglietta J; Greco F; Zamagni C; Garrone O; D'Ostilio N; Sini V; Cannita K; Adamo V; Ricciardi GRR; Fiorio E; Pistelli M; Russo A; et alii...

An Italian Retrospective Survey on Bone Metastasis in Melanoma: Impact of Immunotherapy and Radiotherapy on Survival. in Frontiers in oncology / Front Oncol. 2020 Sep 15;10:1652. doi: 10.3389/fonc.2020.01652. eCollection 2020.

2020
ASL Città di Torino
AO Cuneo

Randon G; Berardi R; Ferrucci PF; Strippoli S; Vitale MG; Ascierto PA; Pigozzo J; Palmieri G; Quadrini S; Cortellini A; Occelli M; Nigro O; Rossi E; Tronconi MC; Marconcini R; Ferraresi V; Quaglino P; Indini A; Guida M; Stucci LS; Di Guardo L; Morgese F; Pala L; Minisini AM; Palla M; Sileni VC; Todisco A; Mandala M; Mannavola F; et alii...

Benefit-risk profile of cytoreductive drugs along with antiplatelet and antithrombotic therapy after transient ischemic attack or ischemic stroke in myeloproliferative neoplasms. in Blood cancer journal / Blood Cancer J. 2018 Feb 28;8(3):25. doi: 10.1038/s41408-018-0048-9.

2018
AO Cuneo

Arellano-Rodrigo E; Bellini M; Cazzola M; Censori B; Finazzi G; Rossi E; Betti S; Cortelezzi A; Cattaneo D; Loscocco GG; Lunghi F; Rapezzi D; Tieghi A; Gaidano G; Musolino C; Ellis MH; Beggiato E; Miroslava P; Carli G; Cacciola R; Hernandez-Boluda JC; Bonifacio M; Palandri F; Griesshammer M; Randi ML; Elli EM; Cervantes F; Rumi E; Finazzi MC; et alii...

A retrospective multicentric observational study of trastuzumab emtansine in HER2 positive metastatic breast cancer: a real-world experience. in Oncotarget / Oncotarget. 2017 May 25;8(34):56921-56931. doi: 10.18632/oncotarget.18176. eCollection 2017 Aug 22.

2017
AO Cuneo

Ciliberto G; Di Cocco B; Marolla P; Sanguineti G; Garrone O; Della Giulia M; Laudadio L; Greco F; Barni S; Lorusso V; Cannita K; Russo A; Adamo V; Giotta F; Tomao S; Ficorella C; Alberti AM; Landucci E; Rossi E; Barba M; Maugeri-Saccà M; Sini V; Mauri M; D'Onofrio L; Scinto AF; Zampa G; Bertolini I; Botticelli A; Piacentini F; et alii...

High rate of recurrent venous thromboembolism in patients with myeloproliferative neoplasms and effect of prophylaxis with vitamin K antagonists. in Leukemia / Leukemia. 2016 Oct;30(10):2032-2038. doi: 10.1038/leu.2016.85. Epub 2016 Apr 26.

2016
AO Cuneo
AOU Novara

Barbui T; Vannucchi AM; Sant'Antonio E; Griesshammer M; Carobbio A; Musolino C; Rapezzi D; Forcina A; Pungolino E; Specchia G; Hernandez-Boluda JC; Tieghi A; Ellis MH; Cacciola R; Palova M; Cattaneo D; Nichele I; Betti S; Rossi E; Gaidano G; Zetterberg E; Vianelli N; Finazzi G; Finazzi MC; Elli E; Randi ML; Alvarez-Larrán A; Iurlo A; Ruggeri M; et alii...

Splanchnic vein thrombosis in myeloproliferative neoplasms: risk factors for recurrences in a cohort of 181 patients. in Blood cancer journal / Blood Cancer J. 2016 Nov 4;6(11):e493. doi: 10.1038/bcj.2016.103.

2016
AO Cuneo

Barbui T; Griesshammer M; Carobbio A; Musolino C; Forcina A; Rapezzi D; Specchia G; Pungolino E; Hernandez-Boluda JC; Tieghi A; Cacciola E; Ellis MH; Palova M; Cattaneo D; Nichele I; Gaidano G; Vianelli N; Zetterberg E; Finazzi G; Finazzi MC; Elli E; Betti S; Guglielmelli P; Rossi E; Pieri L; Randi ML; Iurlo A; Alvarez-Larrán A; Cervantes F; et alii...